1. 2022
  2. ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update

    Ramiro, S., Nikiphorou, E., Sepriano, A., Ortolan, A., Webers, C., Baraliakos, X., Landewé, R. B. M., van den Bosch, F. E., Boteva, B., Bremander, A., Carron, P., Ciurea, A., van Gaalen, F. A., Géher, P. L., Gensler, L., Hermann, J., de Hooge, M., Husakova, M., Kiltz, U., López-Medina, C., & 13 othersMachado, P. M., Marzo-Ortega, H., Molto, A., Navarro-Compán, V., Nissen, M. J., Pimentel-Santos, F. M., Poddubnyy, D., Proft, F., Rudwaleit, M., Telkman, M., Zhao, S. S., Ziade, N. & van der Heijde, D. S., 21 Oct 2022, In: Annals of the rheumatic diseases. 82, 1, p. 19-34 16 p., A78.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. Efficacy and safety of biological DMARDs: a systematic literature review informing the 2022 update of the ASAS-EULAR recommendations for the management of axial spondyloarthritis

    Webers, C., Ortolan, A., Sepriano, A., Falzon, L., Baraliakos, X., Landewé, R. B. M., Ramiro, S., van der Heijde, D. S. & Nikiphorou, E., 21 Oct 2022, In: Annals of the rheumatic diseases. 82, 1, p. 130-141 12 p., A80.

    Research output: Contribution to journalReview articleAcademicpeer-review

  4. Efficacy and safety of non-pharmacological and non-biological interventions: a systematic literature review informing the 2022 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritis

    Ortolan, A., Webers, C., Sepriano, A., Falzon, L., Baraliakos, X., Landewé, R. B. M., Ramiro, S., van der Heijde, D. S. & Nikiphorou, E., 19 Oct 2022, In: Annals of the rheumatic diseases. 82, 1, p. 142-152 11 p., A79.

    Research output: Contribution to journalReview articleAcademicpeer-review

  5. Favorable effect of a 'second hit' after 13 weeks in early RA non-responders: The Amsterdam COBRA treat-to-target randomized trial

    Hartman, L., Rasch, L. A., Turk, S. A., Ter Wee, M. M., Kerstens, P. J. S. M., van der Laken, C. J., Nurmohamed, M. T., van Schaardenburg, D., van Tuyl, L. H. D., Voskuyl, A. E., Boers, M. & Lems, W. F., 7 Oct 2022, (E-pub ahead of print) In: Rheumatology (Oxford, England).

    Research output: Contribution to journalArticleAcademicpeer-review

  6. Sex differences in remission rates over 24 weeks among three different biological treatments compared to conventional therapy in patients with early rheumatoid arthritis (NORD-STAR): a post-hoc analysis of a randomised controlled trial

    Lend, K., van Vollenhoven, R. F., Lampa, J., Lund Hetland, M., Haavardsholm, E. A., Nordström, D., Nurmohamed, M., Gudbjornsson, B., Rudin, A., Østergaard, M., Uhlig, T., Grondal, G., Hørslev-Petersen, K., Heiberg, M. S., Sokka-Isler, T., Koopman, F. A., Twisk, J. W. R. & van der Horst-Bruinsma, I., 1 Oct 2022, In: The Lancet Rheumatology. 4, 10, p. e688-e698

    Research output: Contribution to journalArticleAcademicpeer-review

  7. Improving naive B cell isolation by absence of CD45RB glycosylation and CD27 expression in combination with BCR isotype

    Koers, J., Pollastro, S., Tol, S., Niewold, I. T. G., van Schouwenburg, P. A., de Vries, N. & Rispens, T., Oct 2022, In: European journal of immunology. 52, 10, p. 1630-1639 10 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  8. Longitudinal analysis of anti-drug antibody development in multiple sclerosis patients treated with interferon beta-1a (Rebif™) using B cell receptor repertoire analysis

    van der Weele, L., Pollastro, S., van Schaik, B. D. C., van Kampen, A. H. C., Niewold, I. T. G., Kuijpers, T. W., Warnke, C., Jensen, P. E. H., Kramer, D., Ryner, M., Hermanrud, C., Dönnes, P., Pallardy, M., Spindeldreher, S., on behalf of the ABIRISK Consortium, Deisenhammer, F., Fogdell-Hahn, A. & de Vries, N., 15 Sep 2022, In: Journal of neuroimmunology. 370, 577932.

    Research output: Contribution to journalArticleAcademicpeer-review

  9. Trial of Anti-BDCA2 Antibody Litifilimab for Systemic Lupus Erythematosus

    LILAC Trial Investigators, 8 Sep 2022, In: The New England journal of medicine. 387, 10, p. 894-904 11 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  10. Breakthrough infections with the SARS-CoV-2 omicron (B.1.1.529) variant in patients with immune-mediated inflammatory diseases

    Stalman, E. W., Wieske, L., van Dam, K. P. J., Kummer, L. Y., van Kempen, Z. L. E., Killestein, J., Volkers, A. G., Tas, S. W., Boekel, L., Wolbink, G. J., van der Kooi, A. J., Raaphorst, J., Löwenberg, M., Takkenberg, R. B., D'Haens, G. R. A. M., Spuls, P. I., Bekkenk, M. W., Musters, A. H., Post, N. F., Bosma, A. L., & 39 othersHilhorst, M. L., Vegting, Y., Bemelman, F. J., Voskuyl, A. E., Broens, B., Parra Sanchez, A., van Els, C. C. A. C. M., Wit, J. D., Rutgers, A., de Leeuw, K., Horváth, B., Verschuuren, J. J. G. M., Ruiter, A. M., van Ouwerkerk, L., van der Woude, D., Allaart, C. F., Teng, O. Y. K., van Paassen, P., Busch, M. H., Jallah, P. B. P., Brusse, E., van Doorn, P. A., Baars, A. E., Hijnen, D. J., Schreurs, C. R. G., van der Pol, W. L., Goedee, H. S., Steenhuis, M., Keijzer, S., Keijser, J. B. D., Boogaard, A., Cristianawati, O., ten Brinke, A., Verstegen, N. J. M., Zwinderman, K. A. H., Rispens, T., van Ham, S. M., Kuijpers, T. W. & Eftimov, F., 5 Sep 2022, In: Annals of the rheumatic diseases. 81, 12, p. 1757-1766 10 p., 222904.

    Research output: Contribution to journalArticleAcademicpeer-review

  11. Effects of ixekizumab treatment on structural changes in the sacroiliac joint: MRI assessments at 16 weeks in patients with non-radiographic axial spondyloarthritis

    Maksymowych, W. P., Baraliakos, X., Lambert, R. G., Landewé, R., Sandoval, D., Carlier, H., Lisse, J., Li, X., Hojnik, M. & Østergaard, M., 1 Sep 2022, In: The Lancet Rheumatology. 4, 9, p. e626-e634

    Research output: Contribution to journalArticleAcademicpeer-review

Previous 1 2 3 4 5 6 7 8 ...180 Next

ID: 19914